Advertisement
ADVANCED SEARCH
© 2010
Canadian Medical Association
or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Abstract
Full Text
Submit a response
Services
Email this article to a friend
Alert me to new issues of the journal
Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials
CMAJ Vardakas et al. 179: 1269
Online Appendices
Files in this Data Supplement:
Appendix 1: Outcomes of the randomized controlled trials included in the meta-analysis of the effectiveness of respiratory fluoroquinolones compared with other antibiotics for the treatment of community acquired pneumonia
Appendix 2: Characteristics of randomized controlled trials included in the meta-analysis of the effectiveness of fluoroquinolones compared with other antibiotics for the treatment of community-acquired pneumonia
Appendix 3: Methodological quality and definitions for severe pneumonia and inpatient treatment of the randomized controlled trials included in the meta-analysis of the effectiveness of respiratory fluoroquinolones compared with other antibiotics for the
Appendix 4: Odds ratio of the effectiveness of respiratory fluoroquinolones compared with other antibiotics for the treatment of community-acquired pneumonia by type of funding of the study
Appendix 5: Adverse effects probably or possibly related to study drugs reported in the randomized controlled trials included in the meta-analysis of the effectiveness of fluoroquinolones compared with other antibiotics
This Article
Abstract
Full Text
Submit a response
Services
Email this article to a friend
Alert me to new issues of the journal